Status: active - level 1
Last updated on 31 October 2025
As part of the ANRS MIE Emergence programme, the agency publishes a weekly scientific review on chikungunya, providing updates on the most recent research findings.
In particular, you will find in the scientific review available for download:
Chikungunya is an infectious disease caused by an arbovirus, the chikungunya virus (CHIKV). Between 2005 and 2006, Réunion experienced a major chikungunya epidemic, with an estimated 266,000 symptomatic cases, or 34% of the island’s population. The epidemic was also marked by 258 deaths. The end of the epidemic was officially declared in April 2007 [2].
The immunity acquired during this episode (estimated at 38% of the population of Réunion) declined over time, which could partly explain the resumption of chikungunya virus circulation in Réunion in 2024 [3]. After an absence of three years, 5 confirmed cases of chikungunya were reported in Réunion in 2009 [4]. Between 2010 and 2024, no indigenous cases were detected. [5]. This absence of cases came to an end in August 2024, marking a new turning point in the circulation of the chikungunya virus on the island.
More about chikungunyaBetween August 2024 and July 8, 2025, 54 340 autochthonous cases of chikungunya were confirmed by PCR in Réunion Island, along with 28 deaths.
Despite the official end of the chikungunya epidemic on the island, CHIKV transmission is still decreasing but remains active in the majority of municipalities[1].
Between May 1st, the start of enhanced surveillance, and July 15th, 2025, 799 imported cases of chikungunya were identified in mainland France. Among these imported cases, 646 came from Réunion Island, 32 from Mayotte, 61 from Mauritius, and 37 from Madagascar, where chikungunya outbreaks are currently ongoing.
The first locally acquired case of chikungunya in mainland France in 2025 was reported in early June in the Gard department. As of July 16th, 2025, a total of 31 locally transmitted cases have been recorded, mainly in the regions of Provence-Alpes-Côte d’Azur, Corsica, Occitanie, and Auvergne-Rhône-Alpes, which had already been affected in previous years, and for the first time in Grand Est and Nouvelle-Aquitaine. The number of transmission clusters highlights the significant risk of local transmission of these viruses in mainland France. Additional cases will likely be identified, including outside the usual transmission areas. [Epidemiological Update of July 16, 2025, SpF]